drugset / Trial / NCT01999894

Open-label Study of Safety and Tolerability of Memantine in Children With Autism

NCT01999894

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the long-term safety and tolerability of memantine in the treatment of autism in pediatric patients.

Timeline

Start
2009-11
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 3 mg Oral
Subject Memantine Unknown 6 mg Oral
Subject Memantine Unknown 9 mg Oral
Subject Memantine Unknown 15 mg Oral
Subject Memantine Unknown 18 mg Oral

Indications